Biased Ligands. Better Drugs.

ASCRS - APOLLO-2: TRV130 Abdominoplasty Trial

APOLLO-2: A Randomized, Placebo- and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a Novel μ Receptor G Protein Pathway Selective (μ-GPS) Modulator, for Management of Moderate to Severe Acute Pain Following Abdominoplasty

A Senagore, DG Soergel, DA Burt, F Skobieranda

View PDF

Copyright © Trevena, Inc.